Literature DB >> 23837998

Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.

Alessandra Giavarini1, Antoine Chedid, Guillaume Bobrie, Pierre-François Plouin, Albert Hagège, Laurence Amar.   

Abstract

OBJECTIVE: Phaeochromocytomas and paragangliomas (PPGL) can cause acute catecholamine cardiomyopathy (ACC). We assessed the prevalence of ACC and compared the presentation of cases with and without ACC in a large series of PPGL.
DESIGN: Single centre retrospective study.
SETTING: Hypertension Unit, University Hospital, Paris. PATIENTS: 140 consecutive patients with PPGL, referred from January 2003 to September 2012. MAIN OUTCOME MEASURES: Left ventricular ejection fraction (LVEF), perioperative mortality.
RESULTS: Fifteen patients (11%) had suffered an ACC, occurring in 14 cases before the diagnosis of PPGL. Precipitating factors were identified in 11 cases. Twelve patients presented with acute pulmonary oedema, including 10 with cardiogenic shock, requiring life support in eight cases. Seven patients (five with pulmonary oedema) presented with acute chest pain and cardiac dysfunction. Electrocardiographic abnormalities were present in 14 cases: ST segment elevation or pathological Q waves, ST segment depression, and/or diffuse T wave inversion. Six patients displayed classical (apical ballooning) or inverted (basal/mid ventricular stunning) takotsubo-like cardiomyopathy. Coronary arteries were always normal on angiography. In patients with ACC, median LVEF rose from 30% (IQR 23-33%) during ACC to 71% (50-72%) before surgery (n=11, p<0.001). Median LVEF before PPGL surgery was 65% (51-72%) and 65% (60-70%) in patients with and without a history of ACC, respectively (not significant).
CONCLUSIONS: PPGL may present as ACC in 11% of cases, excluding patients dying from undiagnosed tumours. Left ventricular dysfunction is usually reversible before surgery. PPGL should be suspected in patients with acute heart failure without evidence of valvular or coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23837998     DOI: 10.1136/heartjnl-2013-304073

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  37 in total

1.  Contrast-enhanced ultrasound (CEUS) appearances of an adrenal phaeochromocytoma in a child with Von Hippel-Lindau disease.

Authors:  Faise Al Bunni; Annamaria Deganello; Maria E Sellars; Klaus-Martin Schulte; Mudher Al-Adnani; Paul S Sidhu
Journal:  J Ultrasound       Date:  2014-03-28

2.  Paraganglioma presenting as acute myocardial infarction.

Authors:  Jialu Hu; Deng Ao; Minna Tang; Peng Lv; Rongkui Luo; Yan Yan
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 3.  Autonomic nervous system in Takotsubo syndrome.

Authors:  Sonia Borodzicz; Katarzyna Czarzasta; Grzegorz Opolski; Agnieszka Cudnoch-Jędrzejewska
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

4.  Cardiogenic shock with takotsubo-like cardiomyopathy in functional retroperitoneal paraganglioma.

Authors:  P Shan; L Yu; X Hong; W Huang
Journal:  Herz       Date:  2014-02-19       Impact factor: 1.443

5.  Pheochromocytoma: Another Neuroendocrine Tumor that Substantially Affects the Heart.

Authors:  Run Yu
Journal:  Tex Heart Inst J       Date:  2019-06-01

6.  The evaluation and treatment of endocrine forms of hypertension.

Authors:  Alejandro Velasco; Wanpen Vongpatanasin
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

7.  Recurrence of non-cardiogenic pulmonary edema and sustained hypotension shock in cystic pheochromocytoma.

Authors:  Jin Dai; Shen-Jie Chen; Bing-Sheng Yang; Shu-Min Lü; Min Zhu; Yi-Fei Xu; Jie Chen; Hong-Wen Cai; Wei Mao
Journal:  J Zhejiang Univ Sci B       Date:  2017-05       Impact factor: 3.066

Review 8.  Diagnosis and management of pheochromocytoma: a practical guide to clinicians.

Authors:  Joseph M Pappachan; Diana Raskauskiene; Rajagopalan Sriraman; Mahamood Edavalath; Fahmy W Hanna
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

9.  The Author's Reply: inappropriate adrenoreceptor blockade prior to pheochromocytoma removal - 'A timely reappraisal'.

Authors:  Henrique V Luiz; Run Yu; Katherine Wolf; Ning Miao; Andrew Mannes; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-10-03       Impact factor: 3.478

Review 10.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?

Authors:  Jenn Rachelle U Santos; Alessandra Brofferio; Bruna Viana; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-09-18       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.